Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease
CENTOGENE and Denali Therapeutics Announce Strategic Collaboration to Recruit LRRK2 Patients for Clinical Trials
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for Âą?ÂąTb-KLK3-mAb Phase I Clinical Trial in Australia